What is most important is the trends with the infected group. With such a small placebo sample (3-5 people?), it is hard to draw much from them.
The t-cell response it what Prof Frazer is really looking for. He wants to rid the body of the disease entirely, and this is probably the best method of doing so - outside of nanopartcile technology.
Ann: HSV-2 Interim Results Announcement-AHZ.AX, page-41
-
- There are more pages in this discussion • 191 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.76 |
Change
-0.800(6.37%) |
Mkt cap ! $253.4M | |||
| Open | High | Low | Value | Volume |
| $12.49 | $12.49 | $11.30 | $229.1K | 19.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 131 | $11.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.89 | 158 | 2 |
View Market Depth
| Last trade - 15.53pm 04/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |